For: | Zhang L, Chu CQ. Gut Microbiota-Medication Interaction in Rheumatic Diseases. Front Immunol 2021;12:796865. [PMID: 34925383 DOI: 10.3389/fimmu.2021.796865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Deng B, Tao L, Wang Y. Natural products against inflammation and atherosclerosis: Targeting on gut microbiota. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.997056] [Reference Citation Analysis] |
2 | Topi S, Bottalico L, Charitos IA, Colella M, Di Domenico M, Palmirotta R, Santacroce L. Biomolecular Mechanisms of Autoimmune Diseases and Their Relationship with the Resident Microbiota: Friend or Foe? Pathophysiology 2022;29:507-36. [DOI: 10.3390/pathophysiology29030041] [Reference Citation Analysis] |
3 | Wei M, Chu C. Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 2022. [DOI: 10.1016/j.berh.2021.101741] [Reference Citation Analysis] |